Courier Capital LLC Sells 1,257 Shares of Sanofi (NASDAQ:SNY)

Courier Capital LLC trimmed its position in Sanofi (NASDAQ:SNY) by 7.5% in the fourth quarter, HoldingsChannel reports. The firm owned 15,603 shares of the company’s stock after selling 1,257 shares during the quarter. Courier Capital LLC’s holdings in Sanofi were worth $753,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Northwest Investment Counselors LLC bought a new position in shares of Sanofi in the third quarter valued at approximately $29,000. Concord Wealth Partners boosted its position in Sanofi by 157.8% in the third quarter. Concord Wealth Partners now owns 593 shares of the company’s stock worth $34,000 after purchasing an additional 363 shares during the last quarter. Fortitude Family Office LLC grew its stake in Sanofi by 708.6% in the 3rd quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock valued at $43,000 after purchasing an additional 659 shares during the period. Sunbelt Securities Inc. increased its position in shares of Sanofi by 72.1% during the 3rd quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock valued at $43,000 after purchasing an additional 313 shares during the last quarter. Finally, Ashton Thomas Private Wealth LLC bought a new stake in shares of Sanofi during the 2nd quarter worth $51,000. Hedge funds and other institutional investors own 14.04% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on SNY shares. StockNews.com lowered shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Citigroup raised shares of Sanofi to a “strong-buy” rating in a research report on Tuesday, September 17th. Two research analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $57.50.

Sanofi Stock Down 0.2 %

Shares of NASDAQ SNY opened at $48.61 on Tuesday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.00 and a quick ratio of 0.65. The stock has a market capitalization of $123.36 billion, a PE ratio of 24.80, a P/E/G ratio of 1.23 and a beta of 0.57. Sanofi has a one year low of $45.22 and a one year high of $58.97. The business’s fifty day moving average price is $48.62 and its 200-day moving average price is $52.11.

Sanofi (NASDAQ:SNY) last released its quarterly earnings data on Friday, October 25th. The company reported $1.57 EPS for the quarter, beating the consensus estimate of $0.22 by $1.35. The business had revenue of $13.44 billion for the quarter, compared to the consensus estimate of $16.59 billion. Sanofi had a net margin of 9.96% and a return on equity of 27.45%. The company’s revenue was up 12.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.55 earnings per share. On average, equities research analysts anticipate that Sanofi will post 4.06 EPS for the current year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.